sodium salicylate has been researched along with allyl sulfide in 1 studies
| Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (allyl sulfide) | Trials (allyl sulfide) | Recent Studies (post-2010) (allyl sulfide) |
|---|---|---|---|---|---|
| 2,031 | 50 | 171 | 521 | 20 | 178 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cederbaum, AI; Wu, D | 1 |
1 other study(ies) available for sodium salicylate and allyl sulfide
| Article | Year |
|---|---|
Sodium salicylate increases CYP2E1 levels and enhances arachidonic acid toxicity in HepG2 cells and cultured rat hepatocytes.
Topics: Allyl Compounds; Animals; Antioxidants; Apoptosis; Arachidonic Acid; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Chromans; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Synergism; Hepatocytes; Humans; Lipid Peroxidation; Male; Mixed Function Oxygenases; Protein Synthesis Inhibitors; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Salicylate; Sulfides | 2001 |